201 related articles for article (PubMed ID: 12476637)
1. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2002 Nov; 141(11):994-6, 1008. PubMed ID: 12476637
[TBL] [Abstract][Full Text] [Related]
2. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in breast cancer survivors.
Xydakis AM; Sakkas EG; Mastorakos G
Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
[TBL] [Abstract][Full Text] [Related]
6. [Controversy between estrogen replacement therapy and risk of breast cancer in menopause].
Zárate A
Gac Med Mex; 2002; 138(1):105-7. PubMed ID: 11885123
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
Mortimer JE
Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy (HT) in patients with breast cancer.
Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
[TBL] [Abstract][Full Text] [Related]
10. The controversy of hormone-replacement therapy in breast cancer survivors.
Snyder GM; Sielsch EC; Reville B
Oncol Nurs Forum; 1998 May; 25(4):699-706; quiz 707-8. PubMed ID: 9599353
[TBL] [Abstract][Full Text] [Related]
11. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
Rippy L; Marsden J
Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in breast cancer patients and survivors.
Del Priore G; Hatami M
Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
[TBL] [Abstract][Full Text] [Related]
13. Are older breast carcinoma survivors willing to take hormone replacement therapy?
Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
[TBL] [Abstract][Full Text] [Related]
14. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
[TBL] [Abstract][Full Text] [Related]
15. Management of menopause in women with breast cancer.
Brzezinski A
Isr J Med Sci; 1995; 31(2-3):163-8. PubMed ID: 7744587
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
17. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
Johansen OE; Qvigstad E
Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
19. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
Knobf MT
Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]